- ￥495 - 4890
- TargetMol
- 美国
- T9707
- 2025年07月07日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
零下80~20°C
- 保质期：
Powder: -20°C for 3 years In solvent: -80°C for 2 years
- 英文名：
DB2313
- 库存：
10
- 供应商：
TargetMol
- CAS号：
2170606-74-1
- 规格：
1 mg/5 mg/10 mg/25 mg/50 mg
| 规格： | 1 mg | 产品价格： | ￥495.0 |
|---|---|---|---|
| 规格： | 5 mg | 产品价格： | ￥1210.0 |
| 规格： | 10 mg | 产品价格： | ￥1980.0 |
| 规格： | 25 mg | 产品价格： | ￥3370.0 |
| 规格： | 50 mg | 产品价格： | ￥4890.0 |
Product Introduction
Bioactivity
英文名:DB2313
描述:DB2313 (Carboximidamide) is a potent transcription factor PU.1 inhibitor, IC50=14 nM. DB2313 disrupts the interaction of PU.1 with target gene promoters. DB2313 induces apoptosis of acute myeloid leukemia (AML) cells, and has anticancer effects
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验The Wound Watch: An Objective Staging System for Wounds in the Diabetic (db/db) Mouse Model
As in cancer biology, in wound healing there is a need for objective staging systems to decide for the best treatment and predictors of outcome. We developed in the diabetic (db/db) wound healing model, a staging system, the “wound watch
The leptin receptor deficient db/db mouse has served as a rodent model for obesity and type 2 diabetes for more than 40 years. Diabetic features in db/db mice follow an age-dependent progression, with early insulin resistance followed
proteins into ortholog groups based on their sequence similarity. OrthoMCL?DB is a public database that allows users to browse and view ortholog groups that were pre?computed using the OrthoMCL algorithm. Version 4 of this database contained 116,536
技术资料暂无技术资料 索取技术资料
